IPO News & Commentary
Get the latest insights on new stocks
- Smart ring maker Oura sets terms for $2.1 billion IPO 09/21/26
- US IPO Weekly Winners & Losers 09/20/26
- International IPO Weekly Winners & Losers 09/20/26
- US IPO Week Ahead: Insurance, biotech, and defense materials set to test the IPO market 09/18/26
- US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO 09/18/26
- Spain-based Latin American real estate developer Santa Ana Global Enterprises files for a $16 million US IPO 09/18/26
- Hypertension drug developer Retension Pharmaceuticals files for a $58 million IPO 09/18/26
See more
IPO News By Industry
- Hong Kong-based marketing firm AM PM Group doubles shares offered ahead of $34 million US IPO 08/27/26
- Hong Kong digital marketing provider Poche Technology ups range to $5 to $7 ahead of $38 million US IPO 08/06/26
- SME marketing provider Hartford Creative Group more than triples shares offered ahead of $20 million Nasdaq uplisting 06/26/26
- US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO 09/18/26
- Oil and gas equipment maker VME Companies files for a $30 million IPO 09/18/26
- Hornbeck Offshore Services withdraws $100 million IPO; will trade Wednesday after reverse merger with Helix Energy 09/01/26
- SPAC Silicon Valley Acquisition II files for a $220 million IPO, targeting sectors undergoing structural transformation 09/21/26
- US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO 09/18/26
- SPAC Leader's Advantage Acquisition prices $150 million IPO, targeting chemicals and healthcare 09/18/26
- US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO 09/18/26
- UK-based data center provider Nscale files for an estimated $2.0 billion US IPO 09/18/26
- Messaging infrastructure provider Spectral Capital slashes shares offered by 67% ahead of $5 million Nasdaq uplisting 09/18/26
NYSE IPO News
- US IPO Week Ahead: Insurance, biotech, and defense materials set to test the IPO market 09/18/26
- US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO 09/18/26
- Spain-based Latin American real estate developer Santa Ana Global Enterprises files for a $16 million US IPO 09/18/26
- UK-based data center provider Nscale files for an estimated $2.0 billion US IPO 09/18/26
- SPAC Haymaker Acquisition V prices $250 million IPO, targeting industrial and consumer businesses 09/17/26
Nasdaq IPO News
- SPAC Silicon Valley Acquisition II files for a $220 million IPO, targeting sectors undergoing structural transformation 09/21/26
- Small molecule biotech Iambic Therapeutics files for a $100 million IPO 09/21/26
- siRNA biotech ADARx Pharmaceuticals sets terms for $350 million IPO 09/21/26
- Smart ring maker Oura sets terms for $2.1 billion IPO 09/21/26
- Hypertension drug developer Retension Pharmaceuticals files for a $58 million IPO 09/18/26
Be the in-house IPO Expert
Our clients are focused on catalyzing growth and creating value.
Not scouring the web for IPO data.
Get the information you need in minutes, not hours. With IPO Pro, you have the entire US IPO market at your fingertips.
SPAC Silicon Valley Acquisition II files for a $220 million IPO, targeting sectors undergoing structural transformation
Silicon Valley Acquisition II, a blank check company targeting sectors undergoing structural transformation, filed on Monday with the SEC to raise up to $220 million in an initial public offering. The company plans to raise $220 million by offering 22 million ...read more
Small molecule biotech Iambic Therapeutics files for a $100 million IPO
Iambic Therapeutics, a Phase 1 biotech using its AI platform to develop small molecule cancer therapies, filed on Monday with the SEC to raise up to $100 million in an initial public offering. Iambic Therapeutics is a clinical-stage biotech that pairs...read more
siRNA biotech ADARx Pharmaceuticals sets terms for $350 million IPO
ADARx Pharmaceuticals, a phase 3 biotech developing siRNA therapies for various diseases, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $350 million by offering 21.9 million shares at a price range of $15 to $17. AbbVie...read more